The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members
about
Transcription factor TEAD2 is involved in neural tube closureTAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent mannerWW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZTAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathwayInteraction proteome of human Hippo signaling: modular control of the co-activator YAP1The hippo signaling pathway in development and cancerRegulation of TAZ in cancerSignaling in Fibrosis: TGF-β, WNT, and YAP/TAZ ConvergeConstitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathyStructural insights into the YAP and TEAD complexStructural basis of YAP recognition by TEAD4 in the Hippo pathwayRedundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survivalInsights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domainDefects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complexThe related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cellsThe Hippo signaling pathway in stem cell biology and cancerWhat do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease.Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation.Human transcriptional coactivator with PDZ-binding motif (TAZ) is downregulated during decidualization.Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.Co-expression of FBN1 with mesenchyme-specific genes in mouse cell lines: implications for phenotypic variability in Marfan syndromeThe hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.Vestigial-like-2b (VITO-1b) and Tead-3a (Tef-5a) expression in zebrafish skeletal muscle, brain and notochord.Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activationIdentification of novel Pax8 targets in FRTL-5 thyroid cells by gene silencing and expression microarray analysisCellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathwayAntagonizing scalloped with a novel vestigial construct reveals an important role for scalloped in Drosophila melanogaster leg, eye and optic lobe developmentThe Hippo-YAP pathway: new connections between regulation of organ size and cancer.Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisTranscriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.Concise Review: Stem Cell Microenvironment on a Chip: Current Technologies for Tissue Engineering and Stem Cell BiologyThe Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainMicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.TAZ suppresses NFAT5 activity through tyrosine phosphorylation.
P2860
Q22337426-4BCB0033-D246-4EDD-9DD5-96EB02E28367Q24300175-3BEF5019-E6EE-433F-9E6F-43180F20557FQ24304338-9C5F0D2C-3344-476F-B1B6-9A8D83A06F10Q24307937-D41A261E-26B9-41C6-8267-D8D11A8D085CQ24316087-A34E2ECC-840A-470A-A67E-BB16A1561BAEQ24603986-B87BA8FF-8B60-4084-AD90-ED3A743E0832Q26740462-1153CA45-88B1-4259-BCBE-AD26EE2E1B7BQ26782820-FC4D95B3-2BCE-42DC-A1C3-2A966831D3CCQ27333208-075F68AB-4F43-44FC-9482-095E7BC2C397Q27659386-37C595CB-CDCB-46A0-8A38-A8B13B739088Q27659390-744254B1-6EB9-4C7F-AE3A-FE0DC89CAF26Q28272202-6AC32457-A9CC-41DC-A850-A209150A41B9Q28272433-2C880F03-921C-4696-AC5D-A61567C71A64Q28512949-0B25C80C-EB86-4189-92FA-512BEDD2191FQ28588868-6EAEBECB-F2C7-4AD3-B73A-97C361AF4382Q28728051-7C0A2955-E0E7-471B-AFFD-1F6549ACA79EQ30410176-534A5C16-4523-4CAA-B7E9-AD44DEF2BDC8Q30429628-48E454AB-52B3-4505-A4E9-F97221BB7B7BQ33580168-9E2AE92A-7D47-4411-850F-84FF33459BE7Q33868838-46526FB6-C008-409A-8BB5-F4C03CD0E96BQ33926592-E2B5C5DE-5259-415D-837B-BFE087969BACQ34329711-1DA1AB09-B3B8-452F-941F-29D029C42F38Q34333492-474EE17C-785A-4C65-BD44-95DEF6078478Q34568526-C850441D-B761-4C24-B9AA-045C8A3CFBB8Q34698711-23E345A0-2843-4022-9241-1C78AB0EACE0Q34770004-30DDDED7-95F6-459A-8136-3FD15AF517E2Q34950066-9F687B17-F7EA-4B05-BE84-4C1171D438B0Q35128225-79EF0BBF-7928-475E-A20C-05EB945AC248Q35230502-F42CB5FE-BBF7-4E23-AC53-FFE9FC4F7CADQ35236207-D781279D-375F-495A-A5E5-2F4568B9676AQ35641536-56F9F3B8-F864-4EB5-8EB9-A0E8AC536C21Q35811415-45955F07-629E-4DE9-A8FA-46DF68335B22Q35818801-1477CEB2-F501-4C33-966A-0B6FC42A9ED2Q35832427-D23E6D77-5649-4451-B87B-32B09253BC1CQ36122232-E9B59954-8B6F-41A9-8C62-5F7AEB298E2AQ36164116-51D13BBF-683A-4A21-AD0B-740EAB7AE259Q36212672-B9E35639-0444-4C73-94D9-3B4490781435Q36236290-E8D9D0A7-704E-451D-A5F2-366E3B17F1E6Q36347167-A3C454D1-389F-4ECB-B7CF-13BCD83B2AA4Q36435161-1C4F56CD-D839-4DBF-9F53-362B96A9E444
P2860
The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@ast
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@en
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@nl
type
label
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@ast
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@en
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@nl
prefLabel
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@ast
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@en
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@nl
P2093
P2860
P3181
P356
P1433
P1476
The transcriptional co-activat ...... actor-1 (TEF-1) family members
@en
P2093
Iain K G Farrance
Jeong-Ho Hong
Michael B Yaffe
William M Mahoney
P2860
P304
P3181
P356
10.1042/BJ20041434
P407
P577
2005-05-15T00:00:00Z